NCT01601548 Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy Status COMPLETED Phase NA
NCT01600573 Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ) Status UNKNOWN Phase PHASE1/PHASE2
NCT01591772 Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer Status COMPLETED Phase N/A
NCT01583686 CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01583322 Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01580696 Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01572467 Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors Status COMPLETED Phase N/A
NCT01570582 A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Status UNKNOWN Phase PHASE2
NCT01570218 Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy Status COMPLETED Phase NA
NCT01567891 CT Antigen TCR-redirected T Cells for Ovarian Cancer. Status COMPLETED Phase PHASE1/PHASE2
NCT01556841 The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01544049 Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study Status COMPLETED Phase N/A
NCT01538498 Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer Status COMPLETED Phase N/A
NCT01535157 Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01523678 Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers Status COMPLETED Phase PHASE2
NCT01521325 A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers Status COMPLETED Phase PHASE1
NCT01511055 Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand Status TERMINATED Phase PHASE2
NCT01493505 TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer Status TERMINATED Phase PHASE3